fda compounding semaglutide crackdown news today Intensifies on GLP-1 September 2, 2025: U.S. compounding

Emerging human data suggest that GLP1 receptor agonists may improve central insulin sensitivity and brain glucose handling

Can people over 65 use Retatrutide safely

Signs point to yes on this one

Read the full story here: What GLP1 users need: Food, nutrition and CPG innovation Nestl signals strategic reset in a shifting market The last month marked a critical moment for Nestl, as its CEO Phillip Navratil outlined a broader strategic overhaul aimed at sharpening focus, restoring growth and responding to changing consumer demand

Adequate Testosterone ensures muscles can rebuild between sessions, preventing the gradual breakdown that often accompanies prolonged dieting without hormonal support